Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maintenance treatment with two moisturizing creams in atopic dermatitis
2025-521620-29-01Phase 2Authorised
- Sponsor
- Galenica
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, randomised trial of urea + propylene glycol and urea in atopic dermatitis (AD) (3 arms), sponsored by Galenica. Primary endpoint: Time to relapse of eczema on a defined study area (primary). Planned start Jan 2026; status: authorised.
02
Drugs
urea + propylene glycolurea
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2025-521620-29-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-521620-29-01.